News from WuXi AppTec A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 14, 2018, 01:23 ET WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot

STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, congratulates its partner Ascletis for receiving approval from National Drug...


May 07, 2018, 23:44 ET WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange

WuXi AppTec Co., Ltd. ("WuXi AppTec" or "the Company"; Stock Code: 603259), a leading global pharmaceutical and medical device open-access...


May 06, 2018, 20:00 ET WuXi STA Changzhou Site Passes First U.S. FDA Inspection

The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval STA...


Apr 26, 2018, 20:00 ET WuXi STA Announces to Build a New R&D Center in Shanghai

STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), announces that it has signed an investment agreement with the government of...


Apr 18, 2018, 23:54 ET WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced the opening...


Feb 22, 2018, 02:23 ET WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

STA Pharmaceutical Co., Ltd. (STA), a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule...


Jan 09, 2018, 20:00 ET WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services

The collaboration will focus on co-developing new clinical tests and offering current Mayo tests to health care providers and patients in China....


Nov 17, 2017, 05:40 ET WuXi AppTec Selected by IQVIA Stem Cell Center to Serve as GMP Manufacturer of Advanced Therapies

WuXi AppTec (WuXi), a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform company,...


Oct 17, 2017, 17:30 ET WuXi AppTec Acquires ResearchPoint Global to Better Enable Clinical Development Worldwide

WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that...


Aug 02, 2017, 21:23 ET The U.S. FDA Completed Pre-License Inspection (PLI) of WuXi Biologics cGMP Manufacturing Facilities for Production of TMB-355 (ibalizumab)

WuXi Biologics (2269.HK), a global leading open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Jul 30, 2017, 20:00 ET WuXi's Pharmaceutical Development Services Division Merges with STA

STA Pharmaceutical Co., Ltd. (STA) - a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule...


Jul 23, 2017, 20:00 ET STA Signs Supply Agreement with TESARO

STA Pharmaceutical Co., Ltd. (STA) – a WuXi AppTec subsidiary and the leading open-access capability and technology platform for small molecule...


May 15, 2017, 09:42 ET WuXi AppTec Completes Acquisition of HD Biosciences

WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that...


Mar 29, 2017, 20:00 ET WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC

WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec Affiliate, today...


Mar 26, 2017, 20:00 ET LabNetwork Integrates with Reaxys to Offer Seamless Experience from Chemistry Research to Purchase

LabNetwork, WuXi AppTec's global chemistry ecommerce platform company, today announced a new collaboration with Elsevier, a world-leading provider...


Feb 28, 2017, 19:00 ET WuXi AppTec Lab Testing Division's Bioanalytical Service Unit Passed FDA Inspection

WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform company, today...


Jan 19, 2017, 12:52 ET WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences

SHANGHAI, Jan. 19, 2017 /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and...


Jan 18, 2017, 05:00 ET Novel Anti-IL-6 Antibody for Rheumatoid Arthritis from WuXi-MedImmune Joint Venture Receives Clinical Trial Permit (CTP) from CFDA

Milestone represents first-time approval of biologics CTP for a joint multinational-local company venture in China WuXi AppTec, a global R&D...


Nov 22, 2016, 19:00 ET WuXi Biologics and Prima Signs MOU and Announces Strategic Development and Manufacturing Partnership

WuXi Biologics, a WuXi AppTec group company and a leading open-access R&D capability and technology platform company dedicated to expediting...


Oct 06, 2016, 16:00 ET WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies

 WuXi AppTec (WuXi), a leading pharmaceutical, biotechnology, and medical device technology platform company, celebrated the grand opening of...


Sep 22, 2016, 08:00 ET WuXi Biologics Completes Construction of Asia's Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors

 WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec company,...


Sep 09, 2016, 08:00 ET WuXi AppTec Lab Testing Division and AutoGenomics Form Strategic Partnership to Introduce Advanced Molecular Diagnostic Technology to China

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and...


Aug 15, 2016, 08:00 ET WuXi AppTec's STA Subsidiary Passed Third U.S. FDA Inspection

WuXi AppTec Co. Ltd. (WuXi), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology,...


Aug 08, 2016, 08:00 ET WuXi AppTec's STA Subsidiary Opens Operations in San Diego

 WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology...


Aug 01, 2016, 08:00 ET WuXi AppTec's Research Service Division Collaborates with Pelago Bioscience to Provide CETSA® based Target Engagement Assays

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and...